经颅直流电刺激治疗腹腔镜结直肠癌手术围术期焦虑:一项随机临床试验
这项随机临床试验于2023年3月至8月在徐州医科大学附属医院开展,纳入196例18岁及以上择期腹腔镜结直肠癌根治术患者,随机分为主动经颅直流电刺激组(98例)与假刺激组(98例),于术前一天下午和手术当天上午在左侧背外侧前额叶皮层各进行1次刺激,共2次。主要终点为手术当天至术后3天围术期焦虑发生率(HADS-A量表),主动组38.8% vs 假刺激组70.4%(RR 0.55,95%CI 0.42-0.73,P<.001)。主动组术后谵妄发生率8.2% vs 25.5%,术后3天疼痛NRS中位数1.0(IQR 1.0-1.0)vs 2.0(IQR 2.0-2.0)、PSQI中位数10.5(IQR 10.0-11.0)vs 12.0(IQR 11.0-13.0)、FRAIL指数中位数2.0(IQR 1.0-2.0)vs 2.0(IQR 2.0-3.0)。作者认为经颅直流电刺激可能成为改善结直肠癌手术患者围术期焦虑的新策略。
要点
- 择期腹腔镜结直肠癌根治术患者术前接受2次主动经颅直流电刺激,围术期焦虑发生率38.8% vs 假刺激组70.4%(RR 0.55,95%CI 0.42-0.73,P<.001)。
- 主动经颅直流电刺激组术后谵妄发生率8.2% vs 假刺激组25.5%。
- 术后3天主动组疼痛NRS中位数1.0(IQR 1.0-1.0)vs 假刺激组2.0(IQR 2.0-2.0)。
- 术后3天主动组PSQI中位数10.5(IQR 10.0-11.0)vs 假刺激组12.0(IQR 11.0-13.0),主动组睡眠质量更好。
- 术后3天主动组FRAIL指数中位数2.0(IQR 1.0-2.0)vs 假刺激组2.0(IQR 2.0-3.0)。
适用人群与场景
- 2023年3月至8月在徐州医科大学附属医院招募的18岁及以上、接受择期腹腔镜结直肠癌根治术的患者,共196例(平均[SD]年龄63.5[11.0]岁;男性124例[63.3%])。
诊断标准与关键阈值
- 围术期焦虑采用医院焦虑抑郁量表焦虑亚量表(HADS-A)评估,评分范围0-21分,分值越高焦虑越重。
- 术后谵妄采用意识模糊评估法(Confusion Assessment Method)或重症监护室意识模糊评估法(Confusion Assessment Method intensive care unit scale)评估。
- 疼痛采用10分数字评定量表(NRS)评估,0分为无痛,10分为最痛。
- 衰弱采用FRAIL指数评估,评分范围0-5分,0分为最强健,5分为最衰弱。
- 睡眠质量采用匹兹堡睡眠质量指数(PSQI)评估,评分范围0-21分,分值越高睡眠质量越差。
处置流程与药物剂量
- 主动经颅直流电刺激组于手术前一天下午和手术当天上午在左侧背外侧前额叶皮层接受2次主动经颅直流电刺激;假刺激组在同一时间点接受2次假刺激。
- 主要终点为手术当天至术后3天的围术期焦虑发生率。
研究设计与关键结果
- 随机临床试验,共纳入196例患者,随机分为主动经颅直流电刺激组(98例)与假刺激组(98例),采用意向性治疗分析,分析于2023年9月进行。
- 手术当天第2次经颅直流电刺激后,围术期焦虑发生率主动组38.8% vs 假刺激组70.4%(相对危险度0.55[95%CI 0.42-0.73];P<.001)。
- 术后谵妄发生率主动组8.2% vs 假刺激组25.5%。
- 术后3天疼痛NRS中位数(IQR)主动组1.0(1.0-1.0)vs 假刺激组2.0(2.0-2.0)。
- 术后3天PSQI中位数(IQR)主动组10.5(10.0-11.0)vs 假刺激组12.0(11.0-13.0)。
- 术后3天FRAIL指数中位数(IQR)主动组2.0(1.0-2.0)vs 假刺激组2.0(2.0-3.0)。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 试验注册:中国临床试验注册中心注册号ChiCTR2300068859。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,2次术前经颅直流电刺激与择期结直肠癌根治术患者围术期焦虑发生率降低相关。
- 作者认为,主动经颅直流电刺激还与更好的焦虑评分、疼痛水平和睡眠质量以及术后谵妄和衰弱减少相关。
- 作者认为,经颅直流电刺激可能是改善结直肠癌手术患者围术期焦虑的新策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Perioperative anxiety is prevalent among patients undergoing surgical treatment of cancer and often influences their prognosis. Transcranial direct current stimulation (tDCS) has shown potential in the treatment of various anxiety-related disorders, but data on the impact of tDCS on perioperative anxiety are limited.
OBJECTIVE: To evaluate the effect of tDCS in reducing perioperative anxiety among patients undergoing laparoscopic colorectal cancer (CRC) resection.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from March to August 2023 at the Affiliated Hospital of Xuzhou Medical University. Patients aged 18 years or older undergoing elective laparoscopic radical resection for CRC were randomly assigned to either the active tDCS group or the sham tDCS group. Intention-to-treat data analysis was performed in September 2023.
INTERVENTIONS: Patients were randomly assigned to receive 2 sessions of either active tDCS or sham tDCS over the left dorsolateral prefrontal cortex on the afternoon of the day before the operation and in the morning of the day of operation.
MAIN OUTCOMES AND MEASURES: The main outcome was the incidence of perioperative anxiety from the day of the operation up to 3 days after the procedure, as measured using the Hospital Anxiety and Depression Scale-Anxiety (HADS-A) subscale (range: 0-21, with higher scores indicating more anxiety). Secondary outcomes included postoperative delirium (assessed by the Confusion Assessment Method or Confusion Assessment Method intensive care unit scale); pain (assessed by the 10-point Numeric Rating Scale [NRS], with scores ranging from 0 [no pain] to 10 [worst pain]); frailty (assessed by the Fatigue, Resistance, Ambulation, Illness and Loss of Weight [FRAIL] Index, with scores ranging from 0 [most robust] to 5 [most frail]; and sleep quality (assessed by the Pittsburgh Sleep Quality Index [PSQI], with scores ranging from 0 to 21 and higher scores indicating worse sleep quality) after the 2 sessions of the tDCS intervention.
RESULTS: A total of 196 patients (mean [SD] age, 63.5 [11.0] years; 124 [63.3%] men) were recruited and randomly assigned to the active tDCS group (98 patients) or the sham tDCS group (98 patients). After the second tDCS intervention on the day of the operation, the incidence of perioperative anxiety was 38.8% in the active tDCS group and 70.4% in the sham tDCS group (relative risk, 0.55 [95% CI, 0.42-0.73]; P < .001). Patients in the active tDCS group vs the sham tDCS group were less likely to have postoperative delirium (8.2% vs 25.5%) and, at 3 days after the operation, had lower median (IQR) pain scores (NRS, 1.0 [1.0-1.0] vs 2.0 [2.0-2.0]), better median (IQR) sleep quality scores (PSQI, 10.5 [10.0-11.0] vs 12.0 [11.0-13.0]), and lower median (IQR) FRAIL Index (2.0 [1.0-2.0] vs 2.0 [2.0-3.0]).
CONCLUSIONS AND RELEVANCE: Findings of this randomized clinical trial indicate that administration of 2 preoperative sessions of tDCS was associated with a decreased incidence of perioperative anxiety in patients undergoing elective CRC resection. Active tDCS was also associated with better anxiety scores, pain levels, and sleep quality as well as reduced postoperative delirium and frailty. The findings suggest that tDCS may be a novel strategy for improving perioperative anxiety in patients undergoing CRC resection.
TRIAL REGISTRATION: Chinese Clinical Trial Register Identifier: ChiCTR2300068859.
参考来源
- Li C, Tao M, Chen D, et al. Transcranial Direct Current Stimulation for Anxiety During Laparoscopic Colorectal Cancer Surgery: A Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 38635271. doi:10.1001/jamanetworkopen.2024.6589
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。